ArticleJournal of medical case reports2026
Management of hypoparathyroidism during pregnancy following late maternal diagnosis of DiGeorge syndrome: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypoparathyroidism during pregnancy is an uncommon condition, particularly in nonsurgical patients. DiGeorge syndrome (22q11.2 deletion syndrome), a common microdeletion disorder, presents with highly variable features that often delay diagnosis until adulthood. In the absence of hallmark findings such as congenital heart defects or dysmorphic features, diagnosis can be missed or delayed. This case emphasizes the importance of a systematic approach for clinicians facing low calcium levels during pregnancy. Furthermore, it provides valuable guidance for managing and monitoring hypocalcemia resulting from primary hypoparathyroidism during pregnancy. CASE: We describe a 27-year-old Hispanic woman who presented in the third trimester with chronic, asymptomatic hypocalcemia. Her history included multiple unexplained second-trimester pregnancy losses. She had no prior neck surgery, autoimmune disease, or typical symptoms of hypocalcemia. Biochemical evaluation revealed low serum calcium and suppressed parathyroid hormone levels, consistent with primary hypoparathyroidism. Genetic testing confirmed a 22q11.2 microdeletion, establishing the diagnosis of DiGeorge syndrome. She was treated with moderate-dose cholecalciferol and oral calcium supplements. Activated vitamin D analogues were not needed, as endogenous 1,25-dihydroxyvitamin D levels were adequate and calcium levels remained stable with conservative therapy. With close biochemical monitoring, maternal calcium levels remained within the target range, and she delivered a healthy infant with normal neonatal calcium. However, after stopping supplements postpartum, she developed biochemical hypocalcemia and was lost to follow-up, although she remained asymptomatic.
conclusionThis case highlights the importance of evaluating persistent hypocalcemia during pregnancy, even in the absence of clinical symptoms, and considering genetic causes when acquired etiologies are excluded. The postpartum period requires continued monitoring, as hormonal shifts can unmask calcium imbalance. Early recognition of DiGeorge syndrome carries implications for reproductive counseling, neonatal screening, and long-term family planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.